NEW DOMESTIC SUPPLY SOURCE TO HELP ADDRESS CRITICAL SHORTAGE OF MEDICAL RADIOISOTOPES

Posted on

PROPRIETARY PLATFORM WILL BE CAPABLE OF GENERATING UP TO 12 DIFFERENT RARE ISOTOPES SIMULTANEOUSLY WEST VALLEY CITY, Utah – April 17, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, announced its state-of-the-art facility will open in the first quarter of 2025 in West Valley City, Utah. The 170,000 square foot production […]

Read More

Bench to Bedside 2023 Competition

Posted on

Date & Time: April 17th, 2023 | 6:00p – 8:30p Location: Utah State Capitol Building RSVP & Agenda:  bit.ly/b2b-comp-night-2023 On April 17th, join us at the Utah State Capitol Building for the 13th annual Bench to Bedside Competition Night!  Over the course of the school year, 27 student teams from universities across have come together […]

Read More

BD Introduces Advanced Ultrasound Technology to Help Drive First-Stick Success for IV Insertions

Posted on

BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control FRANKLIN LAKES, N.J., April 11, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched a new, easy-to-use advanced ultrasound device with a specialized probe designed to provide clinicians with optimal […]

Read More

Nelson Labs® Receives ASCA Accreditation from the U.S. FDA

Nelson Labs, a global leader in microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries, announced this week that it is now an ASCA-accredited testing laboratory by the U.S. Food and Drug Administration (FDA) within the category of biocompatibility. ASCA is an accreditation structure of the FDA, wherein accreditation […]

Read More

Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting

In a clinical decision effectiveness study, KidneyIntelX classified more Black vs non-Black patients as high risk for progression of chronic kidney disease, resulting in increased prescription of SGLT2-inhibitor drug therapy Additional study results illustrate how KidneyIntelX is aligned with the Veteran’s Health Administration care practice guidelines for risk assessment in early-stage kidney disease and the introduction […]

Read More

ARUP Laboratories Chooses Gestalt’s PathFlow® Solution for Its Strategic Digital Initiatives

Posted on

SPOKANE, WASHINGTON, and SALT LAKE CITY (April 12, 2023)—Gestalt Diagnostics Inc., a leading provider of artificial intelligence (AI)-powered digital pathology solutions, and ARUP Laboratories, a national academic reference laboratory with hospital and health system clients in all 50 states, today announced that ARUP has selected Gestalt’s award-winning PathFlow® digital platform as the solution to support […]

Read More

Myriad Genetics and SimonMed® Imaging Collaborate to Advance Precision Medicine with New Genetic Risk Assessment Program

New program will increase access to affordable genetic testing while also helping to identify and elevate high-risk patient care SALT LAKE CITY, April 12, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and SimonMed® Imaging, one of the largest independent outpatient medical imaging providers and physician […]

Read More

Recap of 2023 E&I Summit

The 2023 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit), presented by BioUtah and the University of Utah PIVOT Center (PIVOT Center), held March 16 at the Eccles Alumni House at the University of Utah, continued its tradition of bringing together Utah’s life sciences leaders, entrepreneurs and the investor community. This year’s event […]

Read More

Clene announces results of exploratory analysis in treatment of ALS

Posted on

SALT LAKE CITY, March 09, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, today announced new results from exploratory analyses including delayed time to key clinical progression events in people […]

Read More

Spectrum Solutions Acquires Alimetrix, Inc. and Microarrays, Inc. to Expand Laboratory Products and Testing Capabilities

Posted on

SALT LAKE CITY–(BUSINESS WIRE)–Spectrum Solutions® today announced the acquisitions of Alimetrix, Inc., a CLIA and CAP accredited molecular diagnostic laboratory skilled at custom qualitative and quantitative assay development, and Microarrays, Inc., a leader in customer array-based products that are used as biological research tools – gene expression arrays, reverse and forward phase protein arrays. These […]

Read More